Goldman Sachs remains bullish USD/JPY – Japan’s policy mix unsustainable – BOJ buying time


This
via the folks at eFX.

For
bank trade ideas, check
out eFX Plus.
For a limited time, get a 7 day free trial, basic for $79 per month
and premium at $109 per month. Get
it here.

Goldman Sachs maintains a bullish bias on USD/JPY over the coming weeks.

  • “JPY took another hard round-trip on Friday after another apparent large-scale intervention. Japan’s current policy mix is clearly unsustainable; it is intervening in both the fixed income and foreign exchange markets, firmly entrenched in the classic “open-economy trilemma,” as our economists explained this week. But, while ultimately unsustainable, it is “working” to some degree,” GS notes.
  • “The Dollar is currently on a broad appreciation trend of historic proportions, which we think could last a little while longer. So it may not be unreasonable for Japan’s policymakers to use the resources at its disposal to try to buy time and limit the speed of JPY depreciation as much as possible. In the meantime, in a macro backdrop of more Fed hikes, higher global rates (ex-Japan), and our economists’ forecast of a relatively soft landing, the trend in USD/JPY should still be higher,” GS adds.

Buying time is right, its probably the best the BOJ can hope for right now.



Source link

Related articles

Baker Hughes indicators Venezuela offers focusing on oil, gasoline and LNG growth

(WO) — Baker Hughes has signed two agreements geared toward supporting oil and gasoline growth and increasing pure gasoline infrastructure in Venezuela, together with a strategic alliance with state-owned PDVSA targeted on gasoline...

OpenAI is sticking extra adverts in ChatGPT

OpenAI’s newest advert format will put photos of sponsored services and products in your display. The adverts, which OpenAI will start testing within the US later this month, will “initially” seem once you...

What One Liquidity Account Prices a Rising Dealer

Each liquidity account comes with one set of phrases protecting the value the dealer pays, the bounds it trades inside, and the classes the account covers. Regardless of the dealer routes via it...

Zenas BioPharma: Obexelimab Is Being Graded On The Mistaken Curve (NASDAQ:ZBIO)

This text was written byComply withI've a powerful inclination in direction of high-growth corporations, typically treading in sectors poised for exponential growth. My experience lies in understanding and investing in disruptive applied sciences...

Bitcoin Positive factors 2.7% to Begin October as Bulls Close to 2026 Yearly Open

Bitcoin (BTC) is eyeing a key stage as BTC/USD is on the cusp of turning the 2026 yearly candle inexperienced.Key factors:Bitcoin bulls have briefly revisited $87,000 on some exchanges, however the 2026 yearly...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com